Clinical Trials Browser

Withdrawn × pembrolizumab × Endocrine × Clear all

NCT03901378 2021-01-25

Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Gastroenteropancreatic or Lung Neuroendocrine Carcinoma

Phase 2 Withdrawn

Carcinoma, Neuroendocrine